These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 20484479)

  • 1. Treatment of type B insulin resistance: a novel approach to reduce insulin receptor autoantibodies.
    Malek R; Chong AY; Lupsa BC; Lungu AO; Cochran EK; Soos MA; Semple RK; Balow JE; Gorden P
    J Clin Endocrinol Metab; 2010 Aug; 95(8):3641-7. PubMed ID: 20484479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined Immunosuppressive Therapy Induces Remission in Patients With Severe Type B Insulin Resistance: A Prospective Cohort Study.
    Klubo-Gwiezdzinska J; Lange M; Cochran E; Semple RK; Gewert C; Brown RJ; Gorden P
    Diabetes Care; 2018 Nov; 41(11):2353-2360. PubMed ID: 30201849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of type B insulin resistance with rituximab.
    Manikas ED; Isaac I; Semple RK; Malek R; Führer D; Moeller LC
    J Clin Endocrinol Metab; 2015 May; 100(5):1719-22. PubMed ID: 25675382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rituximab therapy for the type B syndrome of severe insulin resistance.
    Coll AP; Thomas S; Mufti GJ
    N Engl J Med; 2004 Jan; 350(3):310-1. PubMed ID: 14724317
    [No Abstract]   [Full Text] [Related]  

  • 5. Type B Insulin Resistance Masquerading as Ovarian Hyperthecosis.
    Brown RJ; Joseph J; Cochran E; Gewert C; Semple R; Gorden P
    J Clin Endocrinol Metab; 2017 Jun; 102(6):1789-1791. PubMed ID: 27911591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy of insulin-like growth factor-1 in a patient with autoantibodies to insulin receptors: a case report.
    Yamamoto T; Sato T; Mori T; Yamakita T; Hasegawa T; Miyamoto M; Hosoi M; Ishii T; Yoshioka K; Tanaka S; Fujii S
    Diabetes Res Clin Pract; 2000 Jul; 49(1):65-9. PubMed ID: 10808065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperalimentation as cause of markedly worsened metabolic control in a patient with autoantibodies to the insulin receptor.
    Vesely DL; Coleman MJ; Kohler PO; Jordan RM; Stanley S
    Am J Med; 1985 Oct; 79(4):504-8. PubMed ID: 3931471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody-Mediated Extreme Insulin Resistance: A Report of Three Cases.
    Kim HN; Fesseha B; Anzaldi L; Tsao A; Galiatsatos P; Sidhaye A
    Am J Med; 2018 Jan; 131(1):102-106. PubMed ID: 28822702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin receptor antibodies and insulin resistance.
    Magsino CH; Spencer J
    South Med J; 1999 Jul; 92(7):717-9. PubMed ID: 10414483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical course of the syndrome of autoantibodies to the insulin receptor (type B insulin resistance): a 28-year perspective.
    Arioglu E; Andewelt A; Diabo C; Bell M; Taylor SI; Gorden P
    Medicine (Baltimore); 2002 Mar; 81(2):87-100. PubMed ID: 11889410
    [No Abstract]   [Full Text] [Related]  

  • 11. Systemic lupus erythematosus with acanthosis nigricans, hyperpigmentation, and insulin receptor antibody.
    Baird JS; Johnson JL; Elliott-Mills D; Opas LM
    Lupus; 1997; 6(3):275-8. PubMed ID: 9104736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type B Insulin Resistance in Peru.
    Zelada H; Gamarra D; Arbañil H; Manrique H
    Am J Med Sci; 2017 Mar; 353(3):258-262. PubMed ID: 28262212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regression of acanthosis nigricans correlates with disappearance of anti-insulin receptor autoantibodies and achievement of euglycemia in type B insulin resistance syndrome.
    Fareau GG; Maldonado M; Oral E; Balasubramanyam A
    Metabolism; 2007 May; 56(5):670-5. PubMed ID: 17445543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful immunosuppressive therapy in a patient with autoantibodies to insulin receptors and immune complex glomerulonephritis.
    Sims RE; Rushford FE; Huston DP; Cunningham GR
    South Med J; 1987 Jul; 80(7):903-6. PubMed ID: 3603112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type B insulin resistance complicated with systemic lupus erythematosus.
    Kawashiri SY; Kawakami A; Fujikawa K; Iwamoto N; Aramaki T; Tamai M; Nakamura H; Origuchi T; Ida H; Eguchi K
    Intern Med; 2010; 49(5):487-90. PubMed ID: 20190490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of insulin resistance by autoantibodies to insulin receptors following on an acute Coxsackie B4 infection.
    el-Reshaid K; al-Mofti S; Stepic NR
    Diabetes Res Clin Pract; 1994 Oct; 25(3):207-10. PubMed ID: 7851276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case report: Successful combination therapy with double-filtration plasmapheresis and rituximab under the condition of the use of a sensor-augmented pump for type B insulin resistance syndrome.
    Osanami A; Kanda M; Sato T; Akazawa C; Baba S; Komatsu H; Murase K; Yamashita T; Yano T
    Front Endocrinol (Lausanne); 2022; 13():997296. PubMed ID: 36157458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment with plasmapheresis, cyclophosphamide, and cyclosporin A in type B syndrome of insulin resistance. Case report.
    Eriksson JW; Bremell T; Eliasson B; Fowelin J; Fredriksson L; Yu ZW
    Diabetes Care; 1998 Aug; 21(8):1217-20. PubMed ID: 9702422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remission of chronic thrombotic thrombocytopenic purpura after treatment with cyclophosphamide and rituximab.
    Zheng X; Pallera AM; Goodnough LT; Sadler JE; Blinder MA
    Ann Intern Med; 2003 Jan; 138(2):105-8. PubMed ID: 12529092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin receptor autoimmunity and insulin resistance.
    Zhou P; Ten S; Sinha S; Ramchandani N; Vogiatzi M; Maclaren N
    J Pediatr Endocrinol Metab; 2008 Apr; 21(4):369-75. PubMed ID: 18556968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.